Vol. 38 No. 2 (2004)

Published: 2013-01-30

Clinical oncology

Tumor markers in clinical oncology

Srdjan Novaković
- PDF
Clinical utility of serine proteases in breast cancer

Tanja Cufer
- PDF
Cathepsins and their inhibitors as tumor markers in head and neck cancer

Primož Strojan
- PDF
Pharmacogenetics of thiopurines: can posology be guided by laboratory data?

Gabriele Stocco, Stefano Martelossi, Giuliana Decorti, Alessandro Ventura, Noelia Malusa, Fiora Bartoli, Tullio Giraldi
- PDF
Development of quantitative RT-PCR assays for wild-type urokinase receptor (uPAR-wt) and its splice variant uPAR-del5

Juliane Farthmann, Leon Holzscheiter, Julia Biermann, Axel Meye, Thomas Luther, Matthias Kotzsch, Fred Sweep, Manfred Schmitt, Paul Span, Viktor Magdolen
- PDF
Ex vivo flow mammalian cell electropulsation

Marie Christine Vernhes, Nathalie Eynard, Marie Pierre Rols, Valentina Ganeva, Justin Teissié
- PDF
Immunohistochemical expression of HER-2/neu in patients with lung carcinoma and its prognostic significance

Gordana Petrusevska, Biljana Ilievska-Poposka, Sašo Banev, Snežana Smickova, Zoran Spirovski
- PDF
New saccharide derivatives of indolo[2,3-b]quinoline as cytotoxic compounds and topoisomerase II inhibitors

Joanna Godlewska, Katarzyna Badowska-Rosłonek, Jan Ramza, Łukasz Kaczmarek, Wanda Peczyńska-Czoch, Adam Opolski
- PDF
Regional comparison of cancer incidence

Nermina Obralić, Faris Gavrankapetanović, Zehra Dizdarević, Osman Durić, Fuad Šišić, Ivan Selak, Snježana Balta, Bakir Nakaš
- PDF